T-Cell Therapy Shows Promise in Rare Sarcomas

(MedPage Today) -- Afamitresgene autoleucel (afami-cel) induced responses in a third of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma (MRCLS), according to results of the phase II SPEARHEAD-1 trial.
At data cutoff, the...